The Effect of Reflective Breathing Therapy Compared With Conventional Breathing Therapy in Patients With Chronic Obstructive Pulmonary Disease (COPD) III-IV

This study has been completed.
Sponsor:
Collaborator:
University of Osnabrueck
Information provided by (Responsible Party):
Klaus Kenn, Klinikum Berchtesgadener Land der Schön-Kliniken
ClinicalTrials.gov Identifier:
NCT01478646
First received: September 30, 2011
Last updated: November 22, 2011
Last verified: November 2011
  Purpose

The purpose of this study is to determine whether different types of breathing therapies in patients with COPD III-IV decrease dyspnea and increase activity.


Condition Intervention
Chronic Obstructive Pulmonary Disease
Other: conventional breathing therapy
Other: reflectory breathing therapy

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Crossover Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: The Effect of Reflective Breathing Therapy Compared With Conventional Breathing Therapy on Dyspnoea and Activity in Patients With COPD III-IV

Resource links provided by NLM:


Further study details as provided by Klinikum Berchtesgadener Land der Schön-Kliniken:

Primary Outcome Measures:
  • Change in BORG-Scale [ Time Frame: Change from pre (minute o) in BORG-scale at directly post intervention (minute 60) ] [ Designated as safety issue: Yes ]
    Instrument for self-reported dyspnea; modified BORG-scale ranges from 1 (no dyspnea) to 10 (maximum dyspnea).


Secondary Outcome Measures:
  • Change in residual volume [ Time Frame: change from pre (minute 0) in residual volume at post (minute 60) intervention ] [ Designated as safety issue: No ]
    measured by a portable spirometry device


Enrollment: 24
Study Start Date: August 2011
Study Completion Date: November 2011
Primary Completion Date: November 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Conventional breathing therapy
first: conventional breathing therapy, second: reflectory breathing therapy
Other: conventional breathing therapy
duration: 60 minutes.
Experimental: Reflectory breathing therapy
first: reflectory breathing therapy second: conventional breathing therapy
Other: reflectory breathing therapy
duration: 60 minutes.

Detailed Description:

In the treatment of COPD-Patients different kinds of breathing therapy techniques are used, but many of them are not reassessed yet.

Dyspnea is one of the predominant symptoms of COPD patients and has negative impacts on the activity of the patients. Dyspnea during exertion leads to avoiding activity and results in a deconditioning of muscles and of the cardiovascular system.

Thus breathing therapy techniques seem to be useful, which may lead to a decrease of dyspnea and an increase of activity.

The purpose of this study is to determine whether reflective breathing therapy is more effective on decreasing dyspnea and increasing activity than conventional breathing therapy.

  Eligibility

Ages Eligible for Study:   45 Years to 75 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • inpatient rehabilitation
  • COPD (Gold stage III and IV)

Exclusion Criteria:

  • severe exacerbation in the last four weeks
  • acute infections
  • fever
  • neuritides
  • severe osteoporosis
  • skin disease
  • manic depression
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01478646

Locations
Germany
Schön Klinik Berchtesgadener Land
Schönau, Bayern, Germany, 83471
Sponsors and Collaborators
Klinikum Berchtesgadener Land der Schön-Kliniken
University of Osnabrueck
Investigators
Study Chair: Klaus Kenn, Dr. med. Schön Klinik Berchtesgadener Land
Principal Investigator: Stella Seeberg University of Osnabrueck
  More Information

No publications provided

Responsible Party: Klaus Kenn, Head physician (department of pulmonology), Klinikum Berchtesgadener Land der Schön-Kliniken
ClinicalTrials.gov Identifier: NCT01478646     History of Changes
Other Study ID Numbers: RAT 2011, KBerchtesgadener
Study First Received: September 30, 2011
Last Updated: November 22, 2011
Health Authority: Germany: Ethics Commission

Keywords provided by Klinikum Berchtesgadener Land der Schön-Kliniken:
breathing therapy
reflective breathing therapy
COPD
chronic obstructive pulmonary disease

Additional relevant MeSH terms:
Respiratory Aspiration
Lung Diseases
Pulmonary Disease, Chronic Obstructive
Lung Diseases, Obstructive
Respiration Disorders
Respiratory Tract Diseases
Pathologic Processes

ClinicalTrials.gov processed this record on August 21, 2014